ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
General Health & Fitness
Nutrition and Supplements
Potential Cardiovascular and Metabolic Beneficial Effects of ω-3 PUFA in MOSH Syndrome
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 185264" data-attributes="member: 13851"><p><strong>Potential Cardiovascular and Metabolic Beneficial Effects of ω-3 PUFA in Male Obesity Secondary Hypogonadism Syndrome </strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong>Abstract: </strong><em><span style="color: rgb(184, 49, 47)">Long-chain ω-3 polyunsaturated fatty acids (PUFAs) are fundamental bio components of lipids and cell membranes. They are involved in the maintenance of cellular homeostasis and they are able to exert anti-inflammatory and cardioprotective actions. Thanks to their potential beneficial effects on the cardiovascular system, metabolic axis, and body composition, we have examined their action in subjects affected by male obesity secondary hypogonadism (MOSH) syndrome.</span></em> <em><span style="color: rgb(184, 49, 47)"><u>MOSH syndrome is characterized by the presence of obesity associated with the alteration of sexual and metabolic functions</u>.</span></em> Therefore, this review article aims to analyze scientific literature regarding the possible benefits of ω-3 PUFA administration in subjects affected by MOSH syndrome. <em><span style="color: rgb(44, 130, 201)">We conclude that there is strong evidence supporting ω-3 PUFA administration and/or supplementation for the treatment and management of MOSH patients.</span></em></p><p><em></em></p><p><em></em></p><p><em></em></p><p><em></em></p><p><em></em></p><p><em></em></p><p><em></em></p><p><em><span style="color: rgb(0, 0, 0)"><strong>5. Summary and Future Perspectives</strong></span> </em></p><p></p><p><span style="color: rgb(184, 49, 47)"><em><strong>In conclusion, there seems to be evidence that ω-3 PUFA consumption may be clinically beneficial in the treatment and clinical management of MOSH patients. The ability of ω-3 PUFAs to act on some pathological aspects of MOSH, such as obesity, inflammation, metabolic and cardiovascular disorders, coupled with their optimal safety profile, leads us to the postulation that ω-3 PUFA assumption could be a valuable tool in ameliorating the clinical manifestations of MOSH syndrome.</strong></em></span></p><p></p><p><strong><span style="color: rgb(44, 130, 201)"><em>In pursuance to assess this conclusion in a definitive manner and in order to define the most advantageous dosage, randomized clinical trials on a large population sample are required. Moreover, it would be interesting and useful to conduct experimental studies exploring the possible effects of ω-3 PUFA consumption on hormone profile, on the sexual sphere (T concentrations), and on body composition. </em></span></strong></p></blockquote><p></p>
[QUOTE="madman, post: 185264, member: 13851"] [B]Potential Cardiovascular and Metabolic Beneficial Effects of ω-3 PUFA in Male Obesity Secondary Hypogonadism Syndrome Abstract: [/B][I][COLOR=rgb(184, 49, 47)]Long-chain ω-3 polyunsaturated fatty acids (PUFAs) are fundamental bio components of lipids and cell membranes. They are involved in the maintenance of cellular homeostasis and they are able to exert anti-inflammatory and cardioprotective actions. Thanks to their potential beneficial effects on the cardiovascular system, metabolic axis, and body composition, we have examined their action in subjects affected by male obesity secondary hypogonadism (MOSH) syndrome.[/COLOR][/I][COLOR=rgb(184, 49, 47)][I][B] [/B][/I][/COLOR][I][COLOR=rgb(184, 49, 47)][U]MOSH syndrome is characterized by the presence of obesity associated with the alteration of sexual and metabolic functions[/U].[/COLOR][/I][B][COLOR=rgb(184, 49, 47)][I][B] [/B][/I][/COLOR][/B]Therefore, this review article aims to analyze scientific literature regarding the possible benefits of ω-3 PUFA administration in subjects affected by MOSH syndrome. [I][COLOR=rgb(44, 130, 201)]We conclude that there is strong evidence supporting ω-3 PUFA administration and/or supplementation for the treatment and management of MOSH patients.[/COLOR] [COLOR=rgb(0, 0, 0)][B]5. Summary and Future Perspectives[/B][/COLOR] [/I] [COLOR=rgb(184, 49, 47)][I][B]In conclusion, there seems to be evidence that ω-3 PUFA consumption may be clinically beneficial in the treatment and clinical management of MOSH patients. The ability of ω-3 PUFAs to act on some pathological aspects of MOSH, such as obesity, inflammation, metabolic and cardiovascular disorders, coupled with their optimal safety profile, leads us to the postulation that ω-3 PUFA assumption could be a valuable tool in ameliorating the clinical manifestations of MOSH syndrome.[/B][/I][/COLOR] [B][COLOR=rgb(44, 130, 201)][I]In pursuance to assess this conclusion in a definitive manner and in order to define the most advantageous dosage, randomized clinical trials on a large population sample are required. Moreover, it would be interesting and useful to conduct experimental studies exploring the possible effects of ω-3 PUFA consumption on hormone profile, on the sexual sphere (T concentrations), and on body composition. [/I][/COLOR][/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
General Health & Fitness
Nutrition and Supplements
Potential Cardiovascular and Metabolic Beneficial Effects of ω-3 PUFA in MOSH Syndrome
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top